Suppr超能文献

酮康唑对健康受试者体内丙咪嗪和地昔帕明药代动力学的影响。

Effect of ketoconazole on the pharmacokinetics of imipramine and desipramine in healthy subjects.

作者信息

Spina E, Avenoso A, Campo G M, Scordo M G, Caputi A P, Perucca E

机构信息

Institute of Pharmacology, University of Messina, Italy.

出版信息

Br J Clin Pharmacol. 1997 Mar;43(3):315-8. doi: 10.1046/j.1365-2125.1997.00539.x.

Abstract

AIMS

The aim of the study was to characterize further the role of CYP3A4 in the metabolism of tricyclic antidepressants.

METHODS

The effect of oral ketoconazole (200 mg day-1 for 14 days) on the kinetics of a single oral dose of imipramine (100 mg) and desipramine (100 mg) was evaluated in two groups of six healthy male subjects.

RESULTS

Ketoconazole administration was associated with a decrease in imipramine apparent oral clearance (from 1.16 +/- 0.21 to 0.96 +/- 0.20 l h-1 kg-1, mean +/- s.d.; P < 0.02), a prolongation in imipramine half-life (from 16.7 +/- 3.3 to 19.2 +/- 5.4 h, P < 0.05) and a decrease in area under the curve of metabolically derived desipramine (from 3507 +/- 1707 to 3180 +/- 1505 nmol l-1 h, P < 0.05), whereas concentrations of 2-hydroxy-imipramine were unaffected. In the subjects given desipramine, no significant changes in desipramine and 2-hydroxy-desipramine kinetics were observed during ketoconazole treatment.

CONCLUSIONS

These findings indicate that ketoconazole, a relatively specific inhibitor of CYP3A4, inhibits the N-demethylation of imipramine without affecting the 2-hydroxylation of imipramine and desipramine. This interaction, confirms that CYP3A4 plays a role in the demethylation of tricyclic antidepressants.

摘要

目的

本研究旨在进一步明确细胞色素P450 3A4(CYP3A4)在三环类抗抑郁药代谢中的作用。

方法

在两组各6名健康男性受试者中,评估口服酮康唑(每日200 mg,共14天)对单次口服剂量丙咪嗪(100 mg)和地昔帕明(100 mg)动力学的影响。

结果

服用酮康唑后,丙咪嗪的表观口服清除率降低(从1.16±0.21降至0.96±0.20 l·h⁻¹·kg⁻¹,均值±标准差;P<0.02),丙咪嗪半衰期延长(从16.7±3.3小时延长至19.2±5.4小时,P<0.05),代谢生成的地昔帕明曲线下面积减小(从3507±1707降至3180±1505 nmol·l⁻¹·h,P<0.05),而2-羟基丙咪嗪的浓度未受影响。给予地昔帕明的受试者在酮康唑治疗期间,地昔帕明和2-羟基地昔帕明的动力学未观察到显著变化。

结论

这些发现表明,酮康唑作为一种相对特异性的CYP3A4抑制剂,抑制丙咪嗪的N-去甲基化,而不影响丙咪嗪和地昔帕明的2-羟基化。这种相互作用证实了CYP3A4在三环类抗抑郁药去甲基化中发挥作用。

相似文献

3
Quantification and mechanism of the fluoxetine and tricyclic antidepressant interaction.
Clin Pharmacol Ther. 1992 Mar;51(3):239-48. doi: 10.1038/clpt.1992.18.
8
Imipramine demethylation in vivo: impact of CYP1A2, CYP2C19, and CYP3A4.
Clin Pharmacol Ther. 1997 Mar;61(3):319-24. doi: 10.1016/S0009-9236(97)90164-8.

引用本文的文献

4
Clinical pharmacokinetics of atomoxetine.托莫西汀的临床药代动力学
Clin Pharmacokinet. 2005;44(6):571-90. doi: 10.2165/00003088-200544060-00002.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验